- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/31 - Peptides having more than 20 amino acidsGastrinsSomatostatinsMelanotropinsDerivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
Patent holdings for IPC class C07K 14/31
Total number of patents in this class: 829
10-year publication summary
|
54
|
58
|
69
|
58
|
58
|
51
|
60
|
53
|
45
|
28
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Cytiva BioProcess R&D AB | 322 |
57 |
| Affibody AB | 113 |
33 |
| The University of Chicago | 1490 |
27 |
| Navigo Proteins GmbH | 132 |
25 |
| Roche Sequencing Solutions, Inc. | 722 |
23 |
| Glaxosmithkline Biologicals S.A. | 1601 |
21 |
| Kaneka Corporation | 4693 |
16 |
| New York University | 1840 |
15 |
| Children's Medical Center Corporation | 1956 |
14 |
| The Regents of the University of California | 20720 |
12 |
| Evaxion Biotech A/S | 43 |
12 |
| GE Healthcare Bio-Sciences AB | 508 |
10 |
| EMD Millipore Corporation | 631 |
9 |
| The Trustees of the University of Pennsylvania | 4414 |
9 |
| The Johns Hopkins University | 5875 |
8 |
| GE Healthcare BioProcess R&D AB | 42 |
8 |
| Abvacc, Inc. | 13 |
8 |
| Bristol-myers Squibb Company | 4729 |
7 |
| JSR Corporation | 2555 |
7 |
| Repligen Corporation | 297 |
7 |
| Other owners | 501 |